• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Experimental comparison of the tuberculostatic activities of INH, INHG and INHG-Na (author's transl)].

作者信息

Orlowski E H, Rosenfeld M, Wolter H, Schunk R

出版信息

Arzneimittelforschung. 1976;26(3):409-16.

PMID:989337
Abstract

In a comparative experimental study the glucuronic acid derivatives of isonicotinoylhydrazone (INH), isonicotinoyl-hydrazone d-glucuronic acid lactone (INHG, Gluronazid) and INH-sodium glucuronid (INHG-N-A, Gluronazid pro infusione) were shown to have the same tuberculostatic activity as INH both in vitro and in vivo. As judged by the serum inhibitory activity the serum level shows a different temporal pattern. After the administration of INHG or INHG-Na, the inhibitory activity reaches its peak later than does INH but remains in the active range essentially longer. The most substantial and, with regard to therapy, most significant difference between INHG or INHG-Na and INH lies in the varying toxicological properties. Both the oral and intravenous LD50 increase in the sequence INH, INHG and INHG-Na. The i.v. LD50 of INHG-Na exceeds the oral LD50. As compared to INH the lower toxicity permits a higher dosage of gluronazide. Thus a continuously higher serum inhibitory activity can be achieved than with a corresponding INH therapy.

摘要

相似文献

1
[Experimental comparison of the tuberculostatic activities of INH, INHG and INHG-Na (author's transl)].
Arzneimittelforschung. 1976;26(3):409-16.
2
Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.抗结核药物的设计与合成:异烟肼席夫碱的制备及其对结核分枝杆菌的活性评价
J Antimicrob Chemother. 2004 Feb;53(2):185-91. doi: 10.1093/jac/dkh041. Epub 2003 Dec 19.
3
In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.异烟肼酰化衍生物对结核分枝杆菌的体外和体内活性
Drug Des Discov. 2003;18(4):103-8.
4
Isonicotinoylhydrazone analogs of isoniazid: relationship between superoxide scavenging and tuberculostatic activities.异烟肼的异烟酰腙类似物:超氧化物清除与抑菌活性之间的关系。
Biochemistry (Mosc). 2002 May;67(5):588-91. doi: 10.1023/a:1015558514432.
5
Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.3-取代-5-羟基-5-三氟[氯]甲基-4,5-二氢-1H-1-(异烟酰基)吡唑的合成及其体外抗分枝杆菌活性
Int J Antimicrob Agents. 2008 Aug;32(2):139-44. doi: 10.1016/j.ijantimicag.2008.03.019. Epub 2008 Jun 20.
6
Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.新型N-(取代)-2-异烟酰肼基碳硫酰胺对耐异烟肼结核病具有高活性的抗分枝杆菌活性。
Biomed Pharmacother. 2009 Jan;63(1):36-9. doi: 10.1016/j.biopha.2008.01.012. Epub 2008 Feb 25.
7
[Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].主要药物对小鼠实验性结核病的杀菌活性(作者译)
Pathol Biol (Paris). 1982 Jun;30(6):444-8.
8
New isoniazid derivatives with improved pharmaco-toxicological profile: Obtaining, characterization and biological evaluation.具有改善的药代动力学/毒理学特性的新型异烟肼衍生物:获得、表征和生物学评价。
Eur J Pharm Sci. 2019 Sep 1;137:104974. doi: 10.1016/j.ejps.2019.104974. Epub 2019 Jun 26.
9
Tetrahydro-2H-1,3,5-thiadiazine-5-(4-pyridylcarboxamide)-2-thione derivatives as prodrugs for isoniazid; synthesis, investigations and in vitro antituberculous activity.四氢-2H-1,3,5-噻二嗪-5-(4-吡啶基甲酰胺)-2-硫酮衍生物作为异烟肼的前药;合成、研究及体外抗结核活性
Pharmazie. 1999 Apr;54(4):244-7.
10
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.

引用本文的文献

1
Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.异烟肼新型席夫碱的制备及其体外和体内抗结核活性
Eur J Med Chem. 2009 Oct;44(10):4169-78. doi: 10.1016/j.ejmech.2009.05.009. Epub 2009 May 21.